Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	4118.38	7818.84	-185.35
Graham Fair Price	41.45	0.48	0.34
PEG	-65.29	-0.04	0.10
Price/Book	-8.63	0.13	0.15
Price/Cash Flow	25.00	-30.50	-40.67
Prices/Earnings	54.31	-3.51	-7.68
Price/Sales	-54.31	4.01	8.78
Price/FCF	25.00	-30.50	-40.67
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	-28.72	0.58	0.82
Operating Margin	0.00	-0.23	-0.23
ROA	-100.00	< 0.005	< 0.005
ROE	< 0.005	< 0.005	-100.00
ROIC	< 0.005	< 0.005	46.66
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	0.02	-0.02	1.14
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.48	-1.00	108.09
EPS QOQ	0.76	-1.00	31.61
FCF QOQ	0.88	-0.22	-75.32
Revenue QOQ	-0.45	1.00	119.79
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	376.33	81.82	-78.26
Days Sales Outstanding (DSO)	13.48	14.26	5.83
Inventory Turnover	0.24	1.10	359.94
Debt/Capitalization	0.34	0.34	-0.06
Quick Ratio	0.86	1.27	47.21
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	1.03	1.03	0.02
Cash	0.15	0.22	46.14
Capex	< 0.005	< 0.005	-100.04
Free Cash Flow	< 0.005	< 0.005	-21.85
Revenue	0.02	0.03	100.04
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	1.38	1.38	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-133.43	5796.76	4244.35
Naive Interpretation	Member

06 - Financial Health · Weak

Rating